Platelet Rich Plasma or PRP is the plasma portion of blood consisting of platelets and related growth factors. 

Platelet Rich Plasma is injected into sites of injuries, particularly tendons.  

PRP is injected directly into the injured tissue, stimulating a healing response. PRP is prepared from your own blood. A simple blood sample is taken and then transferred into a high power centrifuge and concentrating device. A PRP injection can be done in 45 minutes or less.

We use proprietary EmCyte technology to ensure pure PRP product and higher cell counts. Emcyte's PurePRP® II provide upwards of 9.5 billion platelets in a 7mL treatment sample (approximately 1.4 million platelets per microliter). High volumes of deliverable platelets enhances the volumetric activity of platelet growth factors and cytokines in active tissue repair. Platelet alpha granules contain various platelet growth factors that promote tissue repair through cell proliferation, chemotaxis, differentiation, and angiogenesis. Platelet cytokines provide the chemical stimulus needed to mediate cell signaling and migration. The amount of deliverable platelets are clinically significant if you are to attain active tissue repair. It is imperative that your deliverable platelet count be more than 1 million platelets per microliter.

PurePRP® II is unique in that it greatly enhances monocyte concentrations, while giving the end user control over the amount of neutrophils they would like to add to their PRP preparation. PurePRP® II takes advantage of the long term phagocytic and protective properties of the monocytes while avoiding the potential harmful inflammation incurred by large concentrations of neutrophils that go through cellular necrosis. This is another differentiating factor that help to explain the natural success of PurePRP® II in patient outcomes.